Last night CBS reran their
expose of the high cost of cancer drugs in the U.S. which was narrated by
Leslie Stahl - http://www.cbsnews.com/news/the-cost-of-cancer-drugs/
I was appalled the first
time I watched this and doubly appalled the second time I saw it. Here’s what I
remember from watching it:
- The cost of cancer drugs is ridiculously high – no matter where you live.
- Cancer patients in the U.S. pay significantly more for the same exact drug – e.g. Avastin – than cancer victims in other countries.
- By law, drug companies in the U.S. get to charge anything they want for these drugs.
- Dying cancer patients often go broke/bankrupt trying to pay for these exorbitantly expensive drugs.
- The drugs don’t work miracles (like actually cure something) and often just extend lives by weeks or months.
- New cancer drugs rarely offer any important advances in effectiveness or patient benefits.
- Cancer doctors get kick-backs for prescribing the newest, more expensive cancer drugs.
- The only good news is that the good folks at Memorial Sloan Kettering, one of the nation's premier cancer centers, led by Dr. Leonard Saltz is chief of gastrointestinal oncology , have a moral backbone and decided to stop prescribing the newest, prohibitively expensive and not particularly more effective cancer drug.
- They not only decided to stop prescribing it, they wrote a New York Times OP-ED article stating why they decided to do so.
Shockingly, “Right after
their editorial was published, the drug's manufacturer, Sanofi, cut the price
of Zaltrap by more than half” said Dr. Peter Bach Sloan’s in-house expert on
drug costs.
I recommend that you watch
this and, if you live in the U.S., write your congressman. If you don’t live in
the U.S. write your relevant governmental agency and thank them profusely.
No comments:
Post a Comment